B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients
- Jarolim, Petr
- Claggett, Brian L.
- Conrad, Michael J.
- Carpenter, Myra A.
- Ivanova, Anastasia
- Bostom, Andrew G.
- Kusek, John W.
- Hunsicker, Lawrence G.
- Jacques, Paul F.
- Gravens-Mueller, Lisa
- Finn, Peter
- Solomon, Scott D.
- Weiner, Daniel E.
- Levey, Andrew S.
- Pfeffer, Marc A.
DOIAbstract
Approximately 200,000 kidney transplant recipients are living in the US; they are at increased risk for cardiovascular and other adverse outcomes. Biomarkers predicting these outcomes are needed. Using specimens collected during the FAVORIT (Folic Acid for Vascular Outcome Reduction In Transplantation) trial, we determined whether plasma levels of B-type natriuretic peptide (BNP) and cardiac troponin I are associated with adverse outcomes in stable kidney transplant recipients
Add to ORKG